Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)

BACKGROUND: To evaluate the strategy for detection of prostate cancer (PCa) with low prostate specific antigen (PSA) level (2.5–4.0 ng/mL), prostate biopsy patients with low PSA were assessed. We evaluated the risk of low PSA PCa and the strategy for screening low-PSA patients. METHODS: We retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Jae Hoon, Yu, Jiwoong, Song, Wan, Kang, Minyong, Sung, Hyun Hwan, Jeon, Hwang Gyun, Jeong, Byong Chang, Seo, Seong IL, Lee, Hyun Moo, Jeon, Seong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590649/
https://www.ncbi.nlm.nih.gov/pubmed/33107227
http://dx.doi.org/10.3346/jkms.2020.35.e342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590649/
https://www.ncbi.nlm.nih.gov/pubmed/33107227
http://dx.doi.org/10.3346/jkms.2020.35.e342

Ejemplares similares